169 related articles for article (PubMed ID: 36986521)
21. A Pretargeted Imaging Strategy for Immune Checkpoint Ligand PD-L1 Expression in Tumor Based on Bioorthogonal Diels-Alder Click Chemistry.
Qiu L; Tan H; Lin Q; Si Z; Mao W; Wang T; Fu Z; Cheng D; Shi H
Mol Imaging Biol; 2020 Aug; 22(4):842-853. PubMed ID: 31741201
[TBL] [Abstract][Full Text] [Related]
22. Fibroblast Activation Protein (FAP) targeting homodimeric FAP inhibitor radiotheranostics: a step to improve tumor uptake and retention time.
Moon ES; Ballal S; Yadav MP; Bal C; Van Rymenant Y; Stephan S; Bracke A; Van der Veken P; De Meester I; Roesch F
Am J Nucl Med Mol Imaging; 2021; 11(6):476-491. PubMed ID: 35003886
[TBL] [Abstract][Full Text] [Related]
23. Noninvasive Imaging of Tumor PD-L1 Expression Using [
Zhang Y; Ding Y; Li N; Wang S; Zhou S; Li R; Yang H; Li W; Qu J
Mol Pharm; 2023 Jan; 20(1):690-700. PubMed ID: 36541699
[TBL] [Abstract][Full Text] [Related]
24.
Liu Y; Zhang Q; Zhang Y; Wang J; Wu Y; Yang G; Shi J; Wang F; Xu Z; Jing H
Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895905
[TBL] [Abstract][Full Text] [Related]
25. [
Kaihani S; Sadeghzadeh N; Abediankenari S; Abedi SM
Ann Nucl Med; 2022 Nov; 36(11):976-985. PubMed ID: 36097232
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of (99m)Tc-HYNIC-TMTP1 as a tumor-homing imaging agent targeting metastasis with SPECT.
Li F; Cheng T; Dong Q; Wei R; Zhang Z; Luo D; Ma X; Wang S; Gao Q; Ma D; Zhu X; Xi L
Nucl Med Biol; 2015 Mar; 42(3):256-62. PubMed ID: 25516099
[TBL] [Abstract][Full Text] [Related]
27. Preclinical evaluation and pilot clinical study of [
Hu K; Li J; Wang L; Huang Y; Li L; Ye S; Han Y; Huang S; Wu H; Su J; Tang G
Acta Pharm Sin B; 2022 Feb; 12(2):867-875. PubMed ID: 35256951
[TBL] [Abstract][Full Text] [Related]
28. Development of Fibroblast Activation Protein Inhibitor-Based Dimeric Radiotracers with Improved Tumor Retention and Antitumor Efficacy.
Zhao L; Chen J; Pang Y; Fang J; Fu K; Meng L; Zhang X; Guo Z; Wu H; Sun L; Su G; Lin Q; Chen H
Mol Pharm; 2022 Oct; 19(10):3640-3651. PubMed ID: 35917335
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and Preliminary Evaluation of
Ma H; Li F; Shen G; Cai H; Liu W; Lan T; Yang Y; Yang J; Liao J; Liu N
Mol Pharm; 2021 Nov; 18(11):4179-4187. PubMed ID: 34591481
[TBL] [Abstract][Full Text] [Related]
30. Enhanced Detection of Early Pulmonary Fibrosis Disease Using
Chen J; Luo D; Dai Y; Zhou Y; Pang Y; Wu H; Sun L; Su G; Lin Q; Zhao L; Chen H
Mol Pharm; 2024 Jun; ():. PubMed ID: 38899595
[TBL] [Abstract][Full Text] [Related]
31. Evans blue-modified radiolabeled fibroblast activation protein inhibitor as long-acting cancer therapeutics.
Wen X; Xu P; Shi M; Liu J; Zeng X; Zhang Y; Shi C; Li J; Guo Z; Zhang X; Khong PL; Chen X
Theranostics; 2022; 12(1):422-433. PubMed ID: 34987657
[No Abstract] [Full Text] [Related]
32.
Li H; Ye S; Li Li ; Zhong J; Yan Q; Zhong Y; Feng P; Hu K
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2705-2715. PubMed ID: 35290473
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and Evaluation of
Ruan Q; Wang Q; Jiang Y; Feng J; Yin G; Zhang J
J Med Chem; 2023 Apr; 66(7):4952-4960. PubMed ID: 36972467
[TBL] [Abstract][Full Text] [Related]
34. [
Vallejo-Armenta P; Ferro-Flores G; Santos-Cuevas C; García-Pérez FO; Casanova-Triviño P; Sandoval-Bonilla B; Ocampo-García B; Azorín-Vega E; Luna-Gutiérrez M
Pharmaceuticals (Basel); 2022 Jun; 15(6):. PubMed ID: 35745648
[TBL] [Abstract][Full Text] [Related]
35. The potential utility of [
Lan L; Liu H; Wang Y; Deng J; Peng D; Feng Y; Wang L; Chen Y; Qiu L
Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):963-979. PubMed ID: 34410435
[TBL] [Abstract][Full Text] [Related]
36. Head-to-head Intra-individual Comparison of [
Novruzov E; Dendl K; Ndlovu H; Choyke PL; Dabir M; Beu M; Novruzov F; Mehdi E; Guliyev F; Koerber SA; Lawal I; Niegisch G; Debus J; Haberkorn U; Sathekge M; Giesel FL
Mol Imaging Biol; 2022 Aug; 24(4):651-658. PubMed ID: 35349039
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of a New
Farahani AM; Maleki F; Sadeghzadeh N; Abediankenari S; Abedi SM; Erfani M
Anticancer Agents Med Chem; 2020; 20(14):1695-1703. PubMed ID: 32560611
[TBL] [Abstract][Full Text] [Related]
38. 99mTc-labeled RGD-BBN peptide for small-animal SPECT/CT of lung carcinoma.
Liu Z; Huang J; Dong C; Cui L; Jin X; Jia B; Zhu Z; Li F; Wang F
Mol Pharm; 2012 May; 9(5):1409-17. PubMed ID: 22452411
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and Preclinical Evaluation of Novel
Ruan Q; Ding D; Diao L; Feng J; Yin G; Jiang Y; Wang Q; Han P; Jiang J; Zhang J
J Med Chem; 2024 Feb; 67(4):3190-3202. PubMed ID: 38320123
[TBL] [Abstract][Full Text] [Related]
40. (99m)Tc-labeled dimeric octreotide peptide: a radiotracer with high tumor uptake for single-photon emission computed tomography imaging of somatostatin receptor subtype 2-positive tumors.
Dong C; Zhao H; Yang S; Shi J; Huang J; Cui L; Zhong L; Jin X; Li F; Liu Z; Jia B; Wang F
Mol Pharm; 2013 Aug; 10(8):2925-33. PubMed ID: 23768172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]